Navigation Links
Drugs Deter Heart Disease for Transplant Patients

Cholesterol-lowering drugs may help kidney transplant patients reduce their risk of heart attacks, shows a new international study.
Drugs called statins have been shown to minimize cardiovascular disease in people with high cholesterol, and they also reduce the incidence in people with normal cholesterol levels who have other conditions that put them at higher risk for heart problems. Kidney transplant patients have a significantly //higher risk of heart disease. The role cholesterol plays in increasing the risk in this population is unclear due in part to side effects from the immunosuppressive therapy they must receive after a transplant.

Investigators conducted a randomized trial involving about 2,100 kidney transplant patients. About half the group was assigned to take the cholesterol-lowering statin fluvastatin. The other half received a placebo. All were treated for five to six years.

By the end of the study, researchers found fluvastatin had lowered LDL cholesterol levels by 32 percent. While there was no statistically significant difference in cardiovascular events overall in the two groups, those in the fluvastatin group did experience fewer fatal and nonfatal heart attacks -- 70 vs. 104. This finding is similar to results from studies of statin use in other populations.

Researchers conclude fluvastatin may be beneficial in reducing the heart disease risk common in kidney transplant patients. They write, "These findings have implications for the management of cardiovascular risk and for future cardiovascular intervention trials in renal transplantation."
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
(Date:7/25/2008)...alif., July 25 /PRNewswire/ -- AutoGenomics, Inc. ...tatement on Form S-1 with the,Securities and Excha...blic,offering of shares of its common stock. The n... of which are expected to be offered by,AutoGenomi...ve not yet been,determined., J.P. Morgan Securiti...
(Date:7/25/2008)... The Retina Group of New York will prese...cular degeneration especially designed for seniors...ic Library at 116 Merritts Road, Farmingdale, NY 1...ndance is free and refreshments will be provided. ...-6100. , Hicksville and H...
(Date:7/25/2008)... Columbus-based law firm represents Pick...ef purchased at Columbus-area Kroger store , ...uly 25, 2008 -- http://www.donaheyohioinjurylawye... personal injury law firms in central Ohio, has fi... Court (Case No. 08CV9804) against The Kroger Co.,...
(Date:7/24/2008)...inn., July 24 /PRNewswire-FirstCall/ -- ev3 Inc. (...port its 2008 second quarter and,year-to-date fina... quarter,and year-to-date financial results on Mon...ours., The company will host a conference call an...tern Time) on Tuesday, July 29, 2008. ev3,manageme...
Breaking Medicine News(10 mins):Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
... the body from tissue damage also increases the ri...gton University School of Medicine in St. Louis te...thy cells // survive the effects of toxic chemothe... found that the protein encourages the growth of t...
...hwestern Medical Center have identified a step tha...a-amyloid that encourages the spread of the diseas...any other essential roles produces too much beta-a...he whole enzyme knocks out many of its other funct...
... and Molecular Biology (CCMB), Hyderabad has unrav... way for detecting the mechanisms that prevent can... Bhadra and Utpal Bhadra have been instrumental be...t a disease, which has remained a global challenge...
...i following the water borne diseases crossed 55 ev...mic. Most of the 55 dead were from the densely pop... last month's floods. Over 1,000 patients had been...with complications arising from leptospirosis, den...
Other Medicine News:Health News:Researchers Identified Process That Aids Spread Of Alzheimer’s’ Disea 2
(Date:7/22/2008)...e to Patients of Passing a Follow-...ly 22 /- Insmed Inc. (Nasda... biopharmaceuticals, today,announced that Geoffrey...ngressional briefing on Friday, July 25th, 2008 to...approval pathway for follow-on,biologics (FOB) and...
(Date:7/22/2008)...pegylated enzyme produces significantly enhance... - Pegylated enzyme well tolerated -, S...me Therapeutics,Inc. (Nasdaq: HALO ), a biopharm...roducts targeting the extracellular matrix, today,...l animal efficacy data,for its pegylated-rHuPH20 e...
(Date:7/22/2008)...Technology in the European ...ire-FirstCall/ -- Cynosure, Inc.,(Nasdaq: CYNO ),...rray of,light-based aesthetic treatment systems, h...(TM), the company,s high-powered, dual-wavelength,...kin through collagen,remodeling. The CE Mark certi...
(Date:7/22/2008)...k Based on Clinical Data, Preventive Measure Gu...HAM, Mass., July 22 /- Inte...ced the launch of an enhanced test report,format a...lth Genetic Test.,The test is currently marketed u...c Test by Quixtar/Amway. The new report will inclu...
Breaking Medicine Technology:Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference 1904 1Aging Isnt About Slowing Down Experts Say 6810 1Aging Isnt About Slowing Down Experts Say 6810 2St Jude finds molecule that could improve cancer vaccines and therapy for other diseases 6806 1St Jude finds molecule that could improve cancer vaccines and therapy for other diseases 6806 2St Jude finds molecule that could improve cancer vaccines and therapy for other diseases 6806 3Vital Images to Webcast Analyst and Investor Meeting at RSNA on Monday November 26 6802 1Vital Images to Webcast Analyst and Investor Meeting at RSNA on Monday November 26 6802 2
...utomation continues to gain importance in modern c...consolidation, rising demands from clinicians for ...age of licensed medical technologists. Ultimately,...mation solutions are better equipped to meet these...all laboratory automation (e.g. sample processing ...
...tent Editor Medcompare.com ,According to a ...int United Nations Programme on HIV/AIDS) and the ...ving with HIV globally reached an estimated high o... deaths caused by AIDS. The latest data from the ...llion people in the United States are now living w...
Other Medicine Technology:Optimizing Quality Control Data Management 2Optimizing Quality Control Data Management 3Optimizing Quality Control Data Management 4Optimizing Quality Control Data Management 5Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3
Only SurLok combines precise control, enhanced basket and grasper strength, and the added security of a unique wire-locking mechanism. You can feel the difference. The SurLok flat-wire and grasper ha
The SurLok helical stone baskets are constructed of strong and resilient stainless steel. These helical baskets present a spiral profile that effectively clears both stones and fragments.
The 3-way design permits continuous irrigation through a separate irrigation lumen in the Foley Catheter. 3-Way Catheters are available in Latex construction, as well as LUBRICATH coatings, and in a
The Coude tip design facilitates negotiation of the prostatic urethra. It is available in a medium length olive Coude tip with a single drainage eye. The red latex construction provides added stiffne
Medicine Products: